logo-loader
viewRegeneus Ltd

Regeneus enters strategic collaboration

Regeneus (ASX:RGS) has been granted a trading halt by the ASX this morning, with its shares placed in pre-open.

rubber-stamp.jpg
Regeneus has been granted a trading halt.

Regeneus requested the halt pending details on the signing of transaction documents and information relating to the entry into a strategic collaboration and licensing agreement for Progenza stem cell technology in Japan.

The halt will remain in place until the opening of trade on Friday 30th December 2016, or earlier if an announcement is made to the market.

Quick facts: Regeneus Ltd

Price: 0.064 AUD

ASX:RGS
Market: ASX
Market Cap: $17.78 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Alkane Resources hits almost 700 metres of mineralisation in...

Alkane Resources Ltd (ASX:ALK) managing director Nic Earner updates Proactive on follow-up drill results from the Boda prospect within the wider Northern Molong Porphyry Project (NMPP) near Orange in New South Wales. The drilling is part of a 5,000-metre diamond core drilling exploration...

18 hours, 47 minutes ago

2 min read